Skip Header

 
Contribute Send feedback
Read comments (0) or add your own

Reviewed, UniProtKB/Swiss-Prot Q9HCF4 (ALO17_HUMAN)

Last modified November 3, 2009. Version 53. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (3) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Alternative products · Sequence annotation (Features) · Sequences · References · Web resources · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    Protein ALO17
Alternative name(s):
    ALK lymphoma oligomerization partner on chromosome 17
Gene names
Name: KIAA1618
Synonyms: ALO17
OrganismHomo sapiens (Human) [Complete proteome]
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length1550 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is not processed.
Protein existenceEvidence at protein level.

General annotation (Comments)

Involvement in disease

A chromosomal aberration involving ALO17 is associated with anaplastic large-cell lymphoma (ALCL). Translocation t(2;17)(p23;q25) with ALK.

Ontologies

Keywords
   Coding sequence diversityAlternative splicing
Chromosomal rearrangement
Polymorphism
   DiseaseProto-oncogene
   PTMAcetylation
Phosphoprotein
   Technical termComplete proteome
Gene Ontology (GO)
None. [Check GOA]

Alternative products

This entry describes 3 isoforms produced by alternative splicing. [Align] [Select]
Isoform 1 (identifier: Q9HCF4-1)

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
Isoform 2 (identifier: Q9HCF4-2)

The sequence of this isoform differs from the canonical sequence as follows:
     1009-1063: SQTSILQGFS...LADVKHVFRL → VNNLSSWETD...SLAKGNGAEI
     1064-1550: Missing.
Isoform 3 (identifier: Q9HCF4-3)

The sequence of this isoform differs from the canonical sequence as follows:
     87-87: E → EGATSEVLVDAAVDLISDEWEAANAIPSKRRKQDAAPLEAASVPSADCEQ

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 15501550Protein ALO17
PRO_0000253299

Amino acid modifications

Modified residue11881Phosphoserine Ref.5
Modified residue12231N6-acetyllysine Ref.9
Modified residue12581Phosphoserine Ref.6 Ref.7

Natural variations

Alternative sequence871E → EGATSEVLVDAAVDLISDEW EAANAIPSKRRKQDAAPLEA ASVPSADCEQ in isoform 3.
VSP_021007
Alternative sequence1009 – 106355SQTSI…HVFRL → VNNLSSWETDSGSQLCSAMT QLRAMKHPLGLSSSANSEIG KWAPSSLAKGNGAEI in isoform 2.
VSP_021008
Alternative sequence1064 – 1550487Missing in isoform 2.
VSP_021009
Natural variant611P → L: dbSNP rs9913317.
VAR_056735
Natural variant2701M → T: dbSNP rs17857135. Ref.2
VAR_056736

Experimental info

Sequence conflict211 – 2199SGGRGLSQE → LGQRPVPG in CAH10615. Ref.1
Sequence conflict2651Missing in CAH10615. Ref.1
Sequence conflict3211M → T in AAH36891. Ref.2
Sequence conflict3211M → T in AAH40341. Ref.2
Sequence conflict3691K → N in AAH36891. Ref.2

Sequences

Sequence LengthMass (Da)Tools
Isoform 1 [UniParc].

Last modified October 17, 2006. Version 2.
Checksum: 5D15EA328BC385B9

FASTA1,550174,897
        10         20         30         40         50         60 
MECPSCQHVS KEETPKFCSQ CGERLPPAAP IADSENNNST MASASEGEME CGQELKEEGG 

        70         80         90        100        110        120 
PCLFPGSDSW QENPEEPCSK ASWTVQESKK KKRKKKKKGN KSASSELASL PLSPASPCHL 

       130        140        150        160        170        180 
TLLSNPWPQD TALPHSQAQQ SGPTGQPSQP PGTATTPLEG DGLSAPTEVG DSPLQAQALG 

       190        200        210        220        230        240 
EAGVATGSEA QSSPQFQDHT EGEDQDASIP SGGRGLSQEG TGPPTSAGEG HSRTEDAAQE 

       250        260        270        280        290        300 
LLLPESKGGS SEPGTELQTT EQQAGASASM AVDAVAEPAN AVKGAGKEMK EKTQRMKQPP 

       310        320        330        340        350        360 
ATTPPFKTHC QEAETKTKDE MAAAEEKVGK NEQGEPEDLK KPEGKNRSAA AVKNEKEQKN 

       370        380        390        400        410        420 
QEADVQEVKA STLSPGGGVT VFFHAIISLH FPFNPDLHKV FIRGGEEFGE SKWDSNICEL 

       430        440        450        460        470        480 
HYTRDLGHDR VLVEGIVCIS KKHLDKYIPY KYVIYNGESF EYEFIYKHQQ KKGEYVNRCL 

       490        500        510        520        530        540 
FIKSSLLGSG DWHQYYDIVY MKPHGRLQKV MNHITDGPRK DLVKGKQIAA ALMLDSTFSI 

       550        560        570        580        590        600 
LQTWDTINLN SFFTQFEQFC FVLQQPMIYE GQAQLWTDLQ YREKEVKRYL WQHLKKHVVP 

       610        620        630        640        650        660 
LPDGKSTDFL PVDCPVRSKL KTGLIVLFVV EKIELLLEGS LDWLCHLLTS DASSPDEFHR 

       670        680        690        700        710        720 
DLSHILGIPQ SWRLYLVNLC QRCMDTRTYT WLGALPVLHC CMELAPRHKD AWRQPEDTWA 

       730        740        750        760        770        780 
ALEGLSFSPF REQMLDTSSL LQFMREKQHL LSIDEPLFRS WFSLLPLSHL VMYMENFIEH 

       790        800        810        820        830        840 
LGRFPAHILD CLSGIYYRLP GLEQVLNTQD VQDVQNVQNI LEMLLRLLDT YRDKIPEEAL 

       850        860        870        880        890        900 
SPSYLTVCLK LHEAICSSTK LLKFYELPAL SAEIVCRMIR LLSLVDSAGQ RDETGNNSVQ 

       910        920        930        940        950        960 
TVFQGTLAAT KRWLREVFTK NMLTSSGASF TYVKEIEVWR RLVEIQFPAE HGWKESLLGD 

       970        980        990       1000       1010       1020 
MEWRLTKEEP LSQITAYCNS CWDTKGLEDS VAKTFEKCII EAVSSACQSQ TSILQGFSYS 

      1030       1040       1050       1060       1070       1080 
DLRKFGIVLS AVITKSWPRT ADNFDDILKH LLTLADVKHV FRLCGTDEKI LANVTEDAKR 

      1090       1100       1110       1120       1130       1140 
LIAVADSVLT KVVGDLLSGT ILVGQLELII KHKNQFLDIW QLREKSLSPQ DEKCAVEEAL 

      1150       1160       1170       1180       1190       1200 
DWRREELLLL KKEKRCVDSL LKMCGNVKHL IQVDFGVLAV RHSQDLSSKR LNDTMTVRLS 

      1210       1220       1230       1240       1250       1260 
TSSNSQRATH YHLSSQVQEM AGKIDLLRDS HIFQLFWREA AEPLSEPKED QEAAELLSEP 

      1270       1280       1290       1300       1310       1320 
EEESERHILE LQEVYDYLYQ PSYRKFIKLH QDLKSGEVTL AEIDVIFKDF VNKYTDLDSE 

      1330       1340       1350       1360       1370       1380 
LKIMCTVDHQ GQRDWIKDRV EQIKEYHHLH QAVHAAKVIL QVKESLGLNG DFSVLNTLLN 

      1390       1400       1410       1420       1430       1440 
FTDNFDDFRR ETLDQINQEL IQAKKLLQDI SEARCKGLQA LSLRKEFICW VREALGGINE 

      1450       1460       1470       1480       1490       1500 
LKVFVDLASI SAGENDIDVD RVACFHDAVQ GYASLLFKLD PSVDFSAFMK HLKKLWKALD 

      1510       1520       1530       1540       1550 
KDQYLPRKLV SLILSLMQIL LNRALLSNVR AVTVEMVAHL CGRFVHSRFQ 

« Hide

Isoform 2.

Checksum: 986D1CDBC23CAF87
Show »

FASTA1,063118,436
Isoform 3.

Checksum: A86C62AF77D5719D
Show »

FASTA1,599179,976

References

« Hide 'large scale' references
[1]"The full-ORF clone resource of the German cDNA consortium."
Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I.
BMC Genomics 8:399-399(2007) [PubMed: 17974005] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
Tissue: Melanoma.
[2]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), VARIANT THR-270.
Tissue: Eye.
[3]"Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro."
Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.
DNA Res. 7:273-281(2000) [PubMed: 10997877] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 136-1550 (ISOFORM 1).
[4]"Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor."
Cools J., Wlodarska I., Somers R., Mentens N., Pedeutour F., Maes B., De Wolf-Peeters C., Pauwels P., Hagemeijer A., Marynen P.
Genes Chromosomes Cancer 34:354-362(2002) [PubMed: 12112524] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-163 (ISOFORMS 1/2 AND 2/3), CHROMOSOMAL TRANSLOCATION WITH ALK.
[5]"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.
Anal. Sci. 24:161-166(2008) [PubMed: 18187866] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1188, MASS SPECTROMETRY.
[6]"A quantitative atlas of mitotic phosphorylation."
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P.
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1258, MASS SPECTROMETRY.
[7]"Large-scale phosphoproteome analysis of human liver tissue by enrichment and fractionation of phosphopeptides with strong anion exchange chromatography."
Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D., Zou H., Gu J.
Proteomics 8:1346-1361(2008) [PubMed: 18318008] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1258, MASS SPECTROMETRY.
Tissue: Liver.
[8]Colinge J., Superti-Furga G., Bennett K.L.
Submitted (OCT-2008) to UniProtKB
Cited for: IDENTIFICATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY.
[9]"Lysine acetylation targets protein complexes and co-regulates major cellular functions."
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T., Olsen J.V., Mann M.
Science 325:834-840(2009) [PubMed: 19608861] [Abstract]
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-1223, MASS SPECTROMETRY.

Cross-references

Sequence databases

AL832920 mRNA. Translation: CAH10615.1.
BC036891 mRNA. Translation: AAH36891.1.
BC040341 mRNA. Translation: AAH40341.1.
AB046838 mRNA. Translation: BAB13444.1.
AF397204 mRNA. Translation: AAN63520.1.
AF397205 mRNA. Translation: AAN63521.1.
IPIIPI00217287.
IPI00218094.
IPI00642126.
RefSeqNP_066005.2.
UniGeneHs.514554

3D structure databases

ModBaseSearch...

Protein-protein interaction databases

IntActQ9HCF4. 1 interaction.
STRINGQ9HCF4.

PTM databases

PhosphoSiteQ9HCF4.

Proteomic databases

PRIDEQ9HCF4.

Genome annotation databases

EnsemblENST00000319921; ENSP00000324392; ENSG00000180843; Homo sapiens. [Genome view]
ENST00000411702; ENSP00000396478; ENSG00000180843; Homo sapiens. [Genome view]
ENST00000456466; ENSP00000392123; ENSG00000180843; Homo sapiens. [Genome view]
GeneID57714.
KEGGhsa:57714.
UCSCuc002jyf.1. human.
uc002jyg.1. human.

Organism-specific databases

CTD57714.
GeneCardsGC17P075849.
HGNCHGNC:19047. KIAA1618.
PharmGKBPA134898812.
HUGESearch...
GenAtlasSearch...

Phylogenomic databases

OMASANSEIG.

Gene expression databases

ArrayExpressQ9HCF4.
BgeeQ9HCF4.
CleanExHS_KIAA1618.
GenevestigatorQ9HCF4.
GermOnlineENSG00000180843. Homo sapiens.

Family and domain databases

ProtoNetSearch...

Other Resources

NextBio64628.
PMAP-CutDBQ9HCF4.

Entry information

Entry nameALO17_HUMAN
AccessionPrimary (citable) accession number: Q9HCF4
Secondary accession number(s): Q69YK7 expand/collapse secondary AC list , Q8IWF4, Q8IZX1, Q8IZX2, Q8N406
Entry history
Integrated into UniProtKB/Swiss-Prot: October 17, 2006
Last sequence update: October 17, 2006
Last modified: November 3, 2009
This is version 53 of the entry and version 2 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation projectHPI (Human Proteome Initiative)
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Relevant documents

Human chromosome 17

Human chromosome 17: entries, gene names and cross-references to MIM

Human entries with polymorphisms or disease mutations

List of human entries with polymorphisms or disease mutations

Human polymorphisms and disease mutations

Index of human polymorphisms and disease mutations

Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Alternative products · Sequence annotation (Features) · Sequences · References · Web resources · Cross-references · Entry information · Relevant documents